Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma
Open Access
- 1 January 2005
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (24) , 3724-3728
- https://doi.org/10.3748/wjg.v11.i24.3724
Abstract
Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinomaKeywords
This publication has 24 references indexed in Scilit:
- Cyclooxygenase-2 expression in the adenoma-carcinoma sequence of human gallbladderAmerican Journal of Gastroenterology, 2002
- COX‐2 and cancer: a new approach to an old problemBritish Journal of Pharmacology, 2001
- TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.International Journal of Oncology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healingNature Medicine, 1999
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Angiogenic FactorsScience, 1987
- Carcinoma of the gallbladder. Staging, treatment, and prognosisCancer, 1976